Effect of nanocurcumin supplementation on the severity of symptoms and length of hospital stay in patients with COVID-19: A randomized double-blind placebo-controlled trial.

MLA

Honarkar Shafie, Elaheh, et al. “Effect of Nanocurcumin Supplementation on the Severity of Symptoms and Length of Hospital Stay in Patients with COVID-19: A Randomized Double-Blind Placebo-Controlled Trial.” Phytotherapy Research : PTR, vol. 36, no. 2, Feb. 2022, pp. 1013–22. EBSCOhost, https://doi.org/10.1002/ptr.7374.

APA

Honarkar Shafie, E., Taheri, F., Alijani, N., Okhovvat, A. R., Goudarzi, R., Borumandnia, N., Aghaghazvini, L., Rezayat, S. M., Jamalimoghadamsiahkali, S., & Hosseinzadeh-Attar, M. J. (2022). Effect of nanocurcumin supplementation on the severity of symptoms and length of hospital stay in patients with COVID-19: A randomized double-blind placebo-controlled trial. Phytotherapy Research : PTR, 36(2), 1013–1022. https://doi.org/10.1002/ptr.7374

Chicago

Honarkar Shafie, Elaheh, Fateme Taheri, Neda Alijani, Ahmad Reza Okhovvat, Razieh Goudarzi, Nasrin Borumandnia, Leila Aghaghazvini, Seyed Mahdi Rezayat, Saeidreza Jamalimoghadamsiahkali, and Mohammad Javad Hosseinzadeh-Attar. 2022. “Effect of Nanocurcumin Supplementation on the Severity of Symptoms and Length of Hospital Stay in Patients with COVID-19: A Randomized Double-Blind Placebo-Controlled Trial.” Phytotherapy Research : PTR 36 (2): 1013–22. doi:10.1002/ptr.7374.